ISRCTN61799591已完成不适用
An open labelled post marketing surveillance study to evaluate safety and efficacy of a fixed dose combination of cefepime and amikacin in subjects with mild to severe infections
Venus Remedies Limited (India)0 个研究点目标入组 315 人开始时间: 2008年5月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 315
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Hospitalised patients of either sex
- •2. Above 18 years of age
- •3. Clinically diagnosed subjects with moderate to severe infections of:
- •3.1. Febrile neutropenia (n = 110)
- •3.2. Nosocomial pneumonia (n = 110)
- •3.3. Other bacterial infection (n = 91)
排除标准
- •1. History of hypersensitivity reaction or any specific contraindication to penicillin group of drugs
- •2. Hepatic or renal disorder or any heart disorder
- •3. Pregnancy and/or lactation
- •4. History of hearing loss
- •5. Alcoholics
研究者
相似试验
招募中
不适用
Open-Label Post-Marketing Surveillance Study to access safety and efficacy of the BeGraft Coronary Stent Graft System”I20-I25Ischaemic heart diseasesDRKS00004540Firma Bentley InnoMed GmbH30
进行中（未招募）
4 期
A prospective, Post Marketing Surveillance study of omalizumab in Chronic Spontaneous UrticariaCTRI/2015/10/006247ovartis Healthcare Private Limited
进行中（未招募）
1 期
Study To Evaluate The Safety And Efficacy Of Vfend® IV in Korean patientsEUCTR2017-000197-11-Outside-EU/EEAPfizer Inc.400
已完成
4 期
Post-marketing SurveillanceStudy in patients prescribed with Darbepoetin alfaCTRI/2017/04/008338Hetero Drugs Limited503
已完成
4 期
A post-marketing study of the marketed product Maxtra® PDS syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031188Zuventus Healthcare Limited200